Document is current

Any future updates will be listed below

Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study

Crossref DOI link: https://doi.org/10.1136/bmjdrc-2019-000807

Published Online: 2020-01-14

Published Print: 2020-01

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark